Confluence Pharmaceuticals - Crunchbase Company Profile & Funding

Q: Who invested in Confluence Pharmaceuticals?

Confluence Pharmaceuticals has 4 investors including IU Ventures And IU Ventures.

Q: How much funding has Confluence Pharmaceuticals raised to date?

Confluence Pharmaceuticals has raised obfuscated.

Overview

Confluence Pharmaceuticals

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Confluence Pharmaceuticals

CB Rank

132320

Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders

Founded

obfuscation

Private

Venture - Series Unknown

Indianapolis, Indiana, United States

1-10

www.confluencepharma.com/

Biotechnology

Pharmaceutical

Therapeutics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Convertible Note

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Boyd W. Sturdevant: Chairman and Founder
Timothy F. Parshall: Vice President of Corporate Affairs

Details

Legal Name

Confluence Pharmaceuticals LLC

Operating Status

Active

Company Type

For Profit

Founders

Boyd W. Sturdevant, Steven L. Johns

About the Company

Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders. The company's current focus is advancing a novel drug discovery that improves social and communication impairments for individuals with Autism Spectrum Disorders and Fragile X Syndrome.

Phone Number

+113173797498

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Therapeutic Treatments for Social and Communication Impairments

Develops therapeutic medications targeting core social and communication impairments caused by Fragile X Syndrome, Autism, and related disorders.

Research & Development

Confluence Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Confluence Pharmaceuticals	1	obfuscated obfuscation	IU Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Confluence Pharmaceuticals	1	obfuscated obfuscation	IU Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Confluence Pharmaceuticals	1	obfuscated obfuscation	IU Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Confluence Pharmaceuticals	1	obfuscated obfuscation	IU Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Confluence Pharmaceuticals	1	obfuscated obfuscation	IU Ventures	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Confluence Pharmaceuticals	1	obfuscated obfuscation	IU Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Confluence Pharmaceuticals	1	obfuscated obfuscation	IU Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Confluence Pharmaceuticals	1	obfuscated obfuscation	IU Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Confluence Pharmaceuticals	1	obfuscated obfuscation	IU Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Confluence Pharmaceuticals	1	obfuscated obfuscation	IU Ventures	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
IU Ventures	Yes	Venture Round - Confluence Pharmaceuticals	Teri F. Willey
IU Ventures	Yes	Venture Round - Confluence Pharmaceuticals	Teri F. Willey
IU Ventures	Yes	Venture Round - Confluence Pharmaceuticals	Teri F. Willey
IU Ventures	Yes	Venture Round - Confluence Pharmaceuticals	Teri F. Willey
IU Ventures	Yes	Venture Round - Confluence Pharmaceuticals	Teri F. Willey